... Gabapentin (marketed as Neurontin), Lamotrigine (marketed as Lamictal), Levetiracetam (marketed as Keppra), Oxcarbazepine (marketed as Trileptal), ...
Cheap copies cut into sales of Trileptal for epilepsy and the Lotrel hypertension drug. Two other products were also hurt by generics, and Novartis lost ...
11-- Oxcarbazepine (Trileptal) failed to hold off severe migraine headaches despite earlier data suggesting it did, researchers found. ...
Oxcarbazepine—marketed as Trileptal by Novartis or Trexapin by Taro—is used alone or in combination with other medications to treat certain types of ...
Oxcarbazepine Tablets, marketed by Novartis as Trileptal® Tablets, is a prescription pharmaceutical product used in treating seizures. ...
... oxcarbazepine (Trileptal, Novartis), pregabalin (Lyrica, Pfizer); tiagabine (Gabitril, Cephalon, Inc), topiramate (Topamax, Ortho-McNeil Pharmaceutical, ...
The increase is primarily due to the launch of Oxcarbazepine Tablets (oxcarbazepine), which is a generic version of Trileptal, partially offset by price ...
... Gabapentin (marketed as Neurontin), Lamotrigine (marketed as Lamictal), Levetiracetam (marketed as Keppra), Oxcarbazepine (marketed as Trileptal), ...
The Detroit-based company attributed the increases primarily to the launch of Oxcarbazepine Tablets, a generic version of the seizure medicine Trileptal. ...
... Laboratories Ltd reported record sales over the past quarter, most likely from the sales of Oxcarbazepine Tablets, a generic form of Trileptal. ...